Silver Book Fact

Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of life–rating it as low or lower than patients with renal failure and AIDS.

Bass E, Marsh M, Mangione C, Bressler N, et al. Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale. Arch Opthalmol. 2004; 122(12): 1856-67. http://archopht.ama-assn.org/cgi/content/abstract/122/12/1856

Reference

Title
Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale
Publication
Arch Opthalmol
Publication Date
2004
Authors
Bass E, Marsh M, Mangione C, Bressler N, et al
Volume & Issue
Volume 122, Issue 12
Pages
1856-67
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • DR Quality of Life
    A quality of life survey of legally blind DR patients found that 41% would be willing to trade their remaining years for perfect vision.  
  • Close to 50% of participants in the NEI-sponsored Los Angeles Latino Eye Study (LALES) who had diabetes, also had diabetic retinopathy.  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using medications and vitamins was $806.  
  • By 2020, the number of Americans age 40 and older who are blind or have low vision is projected to reach 5.5 million– growing from 3.3 million in 2004.  
  • Percent of Blindness in 2010 Due to DR by Region